UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments
During the 2013–2016 Ebola outbreak in West Africa an expert panel was established on the instructions of the UK Prime Minister to identify priority pathogens for outbreak diseases that had the potential to cause future epidemics. A total of 13 priority pathogens were identified, which led to the pr...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Elsevier
2019
|
| _version_ | 1826288536370806784 |
|---|---|
| author | Noad, RJ Simpson, K Fooks, AR Hewson, R Gilbert, SC Stevens, MP Hosie, MJ Prior, J Kinsey, AM Entrican, G Simpson, A Whitty, CJM Carroll, MW |
| author_facet | Noad, RJ Simpson, K Fooks, AR Hewson, R Gilbert, SC Stevens, MP Hosie, MJ Prior, J Kinsey, AM Entrican, G Simpson, A Whitty, CJM Carroll, MW |
| author_sort | Noad, RJ |
| collection | OXFORD |
| description | During the 2013–2016 Ebola outbreak in West Africa an expert panel was established on the instructions of the UK Prime Minister to identify priority pathogens for outbreak diseases that had the potential to cause future epidemics. A total of 13 priority pathogens were identified, which led to the prioritisation of spending in emerging diseases vaccine research and development from the UK. This meeting report summarises the process used to develop the UK pathogen priority list, compares it to lists generated by other organisations (World Health Organisation, National Institutes of Allergy and Infectious Diseases) and summarises clinical progress towards the development of vaccines against priority diseases. There is clear technical progress towards the development of vaccines. However, the availability of these vaccines will be dependent on sustained funding for clinical trials and the preparation of clinically acceptable manufactured material during inter-epidemic periods.
|
| first_indexed | 2024-03-07T02:15:11Z |
| format | Conference item |
| id | oxford-uuid:a1f9504d-92ad-4e1c-9b83-1fe191f50a4b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:15:11Z |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:a1f9504d-92ad-4e1c-9b83-1fe191f50a4b2022-03-27T02:17:05ZUK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developmentsConference itemhttp://purl.org/coar/resource_type/c_5794uuid:a1f9504d-92ad-4e1c-9b83-1fe191f50a4bEnglishSymplectic ElementsElsevier2019Noad, RJSimpson, KFooks, ARHewson, RGilbert, SCStevens, MPHosie, MJPrior, JKinsey, AMEntrican, GSimpson, AWhitty, CJMCarroll, MWDuring the 2013–2016 Ebola outbreak in West Africa an expert panel was established on the instructions of the UK Prime Minister to identify priority pathogens for outbreak diseases that had the potential to cause future epidemics. A total of 13 priority pathogens were identified, which led to the prioritisation of spending in emerging diseases vaccine research and development from the UK. This meeting report summarises the process used to develop the UK pathogen priority list, compares it to lists generated by other organisations (World Health Organisation, National Institutes of Allergy and Infectious Diseases) and summarises clinical progress towards the development of vaccines against priority diseases. There is clear technical progress towards the development of vaccines. However, the availability of these vaccines will be dependent on sustained funding for clinical trials and the preparation of clinically acceptable manufactured material during inter-epidemic periods. |
| spellingShingle | Noad, RJ Simpson, K Fooks, AR Hewson, R Gilbert, SC Stevens, MP Hosie, MJ Prior, J Kinsey, AM Entrican, G Simpson, A Whitty, CJM Carroll, MW UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments |
| title | UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments |
| title_full | UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments |
| title_fullStr | UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments |
| title_full_unstemmed | UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments |
| title_short | UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments |
| title_sort | uk vaccines network mapping priority pathogens of epidemic potential and vaccine pipeline developments |
| work_keys_str_mv | AT noadrj ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT simpsonk ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT fooksar ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT hewsonr ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT gilbertsc ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT stevensmp ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT hosiemj ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT priorj ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT kinseyam ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT entricang ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT simpsona ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT whittycjm ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments AT carrollmw ukvaccinesnetworkmappingprioritypathogensofepidemicpotentialandvaccinepipelinedevelopments |